What Eli Lilly’s new employer platform could mean for access to weight-loss drugs
Lilly Employer Connect aims to make obesity treatments more predictable for employers while lowering costs for workers seeking Zepbound. Eli Lilly wants to get its obesity drugs into the hands of more Americans and it’s betting on employers to help do so.